News
OMIC Blog | Subscribe (RSS) |
- Board Chair Dr Robert Gold pledges to continue OMIC’s strong relationship with the AAO
It is my great honor and privilege to be your new chair of OMIC since the beginning of 2023. Now in our 36th year, we currently insure more than 6,000 ophthalmologists and provide our members with the finest claim defense and first class risk management resources and education. We are financially secure with a healthy […]
- COVID-19: Easing of HIPAA requirements while practicing telemedicine
Two important changes in telehealth that were announced yesterday: Easing of HIPAA requirements while practicing telemedicine: https://www.cmadocs.org/newsroom/news/view/ArticleId/48761/President-suspends-HIPAA-penalties-to-facilitate-telehealth-effective-immediately New CMS benefits https://www.cms.gov/newsroom/press-releases/president-trump-expands-telehealth-benefits-medicare-beneficiaries-during-covid-19-outbreak
- March 2020: New and Revised Retina Consent Forms
We wanted to let you know about some new and revised consent forms. Please revise these sample forms as needed for your patient population. Retina forms BEOVU revised to add retinal artery occlusion to the list of possible complications. Avastin, BEOVU, Eylea, and Lucentis revised to make clearer the discussion of problems following injections, and […]
- Recent FDA recommendation for voluntary recall related to AmEx Pharmacy products
UPDATE: FDA recommends voluntary recall and warns against use of AmEx Pharmacy sterile products We updated our advice of 7/3/19 to clarify that the FDA recommended a voluntary recall (but no recall occurred) and warned against the use of AmEx Pharmacy sterile products. This update also provides more details. In May 2019, the FDA inspected […]